Lv12
50 积分 2025-07-07 加入
The sialoadhesin CD33 is a myeloid-specific inhibitory receptor
15天前
已完结
ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2
16天前
已完结
CD123/CD33 dual-antibody modified liposomes effectively target acute myeloid leukemia cells and reduce antigen-negative escape
16天前
已完结
CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance
20天前
已完结
Influence of CD33 Expression Levels and ITIM-Dependent Internalization on Gemtuzumab Ozogamicin-Induced Cytotoxicity
21天前
已关闭
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window
22天前
已完结
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse
1个月前
已完结
Targeting CD33+ Acute Myeloid Leukemia with GLK-33, a Lintuzumab–Auristatin Conjugate with a Wide Therapeutic Window
1个月前
已完结
Development of an anti-LAIR1 antibody-drug conjugate for acute myeloid leukemia therapy
2个月前
已完结
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)
3个月前
已完结
皖公网安备34019202002308
